Product
IPV
3 clinical trials
9 indications
Indication
Rotavirus GastroenteritisIndication
G2Indication
Grade 3 (G3)Indication
G4Indication
G9Indication
ApneaIndication
Neonatal ApneaIndication
Premature BirthIndication
PoliomyelitisClinical trial
A Phase 3 Randomized, Open-Label, Clinical Trial to Study the Immunogenicity and Safety of Concomitant and Non-Concomitant Administration of V260 and Inactivated Poliomyelitis Vaccine (IPV) in Chinese Healthy InfantsStatus: Completed, Estimated PCD: 2021-05-08
Clinical trial
A Prospective, Randomized, Open-label Clinical Trial to Assess Apnea Following Administration of 13-valent Conjugate Pneumococcal Vaccine, Diphtheria Toxoid, Tetanus Toxoid, and Acellular Pertussis Vaccine, Inactivated Polio Vaccine, Hepatitis B Vaccine, and Haemophilus Influenzae Type B Vaccine in Preterm InfantsStatus: Completed, Estimated PCD: 2021-11-01
Clinical trial
A Phase 3, Open-label, Multicenter Randomized Trial to Evaluate Humoral Immunogenicity of Various Schedules of Intramuscular Full-Dose and Intradermal Fractional Dose of Inactivated Polio Vaccine in Latin American InfantsStatus: Completed, Estimated PCD: 2018-11-13